Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 7 months ago Source:  Radcliffe Cardiology
The long-standing practice of prescribing beta-blockers after a myocardial infarction (MI) has been re-examined in the contemporary era of reperfusion therapy. New findings from the REBOOT-CNIC trial suggest that for patients with a preserved left ventricular ejection fraction (LVEF), this routine therapy may not provide the expected benefits.¹REBOOT-CNIC was an open-label, randomised trial… View more
Author(s): Gabriella Captur Added: 8 months ago
Discover different imaging options for the diagnosis of cardiomyopathies from Dr Gabriella Captur (Royal Free London NHS Foundation Trust, London, UK).This two-part video lecture series, part of Women As One's CLIMB® 2025 Skills Training Program, provides a comprehensive overview of key treatments and therapy approaches to cardiomyopathies.Dr Captur explores cardiac imaging techniques for the… View more
Author(s): James Burton, Clara Bonanad Lozano, Aaron Wong ,et al Start date: Jul 02, 2025
.img-row:after { content: ""; clear: both; display: table; } .img-column { float: left; width: 50%; padding: 5px; } @media screen and (max-width: 500px) { .img-column { width: 100%; } } Join James Burton (University of Leicester, Leicester, UK), Clara Bonanad (University Clinical Hospital of Valencia, Valencia, ES), Aaron Wong (Princess of Wales Hospital, Bridgend, Wales, UK)… View more
Author(s): Harriette Van Spall , Dan Atar , Anna Meta Dyrvig Kristensen Added: 7 months ago
ESC Congress 2025 - Long-term beta-blocker therapy after myocardial infarction reduced the primary endpoint of death from any cause or major adverse cardiovascular events.Late-breaker host Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Dan Atar (Oslo University Hospital Ulleval, NO) and Dr Anna Meta Dyrvig Kristensen (Bispebjerg and Frederiksberg Hospital, DK) to discuss the… View more
Added: 5 months ago Source:  Radcliffe Cardiology
Differentiating cardiac amyloidosis (CA) from its phenotypic mimics remains a clinical challenge. A new study published in the European Heart Journal details the development and validation of a novel artificial intelligence (AI) model that can accurately screen for CA using only a single apical four-chamber echocardiogram video clip.¹This retrospective, multisite, multiethnic study first trained… View more
Author(s): Frederick Welt Added: 6 months ago
Learn about haemodynamic guidance in cardiogenic shock, including early intervention, device selection, and exit strategies, from Dr Frederick Welt (University of Utah, US)This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr… View more
Author(s): Babar Basir, Balimkiz Senman, Jacob E Møller Start date: Aug 02, 2024
In this insightful webinar, Dr Babar Basir (Henry Ford Heart and Vascular Institute, Detroit, MI, US) is joined by Dr Balimkiz Senman (Duke University Hospital, Boston, MA, US) and Prof Jacob Møller (Odense University Hospital, Odense, DE) to delve into the findings of the DanGer Shock trial, recently presented at the American College of Cardiology (ACC) Conference in April 2024. This session… View more
Research Area(s) / Expertise: Job title: Cardio-oncologist
Dr Dan Lenihan is a cardio-oncologist specialising in cardiology, heart disease and advanced heart failure, atSaint Francis Healthcare System, Cape Girardeau, US.He is a co-Founder and Board Member of the International Cardio-Oncology Society (ICOS), which is an international professional association whose primary goal is to eliminate cardiac disease as a barrier to effective cancer therapy.He is… View more